Prime 10 Startup and Tech Funding Information – Week Ending August 1, 2025

It’s Friday, August 1, 2025, and we’re again with the highest 10 startup and tech funding news tales that formed the week. We’re a bit late hitting ship right this moment, however we’ve greater than made up for it with a loaded version—filled with among the boldest raises and most formidable founders scaling new frontiers in AI, biotech, fintech, and robotics.

As July turns to August, enterprise capital funding is pouring into startups throughout the globe. This week (July 28 – August 1, 2025) noticed a number of mega-rounds — together with a half-billion-dollar elevate by fintech unicorn Ramp — and quite a few nine-figure investments fueling breakthroughs in synthetic intelligence, robotics, biotech, and extra. From AI “co-pilots” for finance and energy-efficient AI chips, to novel most cancers therapies and autonomous protection programs, founders are securing large backing to scale their visions. Main buyers like Iconiq Capital, Goldman Sachs, Perception Companions, and B Capital led the cost, joined by company strategics comparable to Sanofi and Google’s DeepMind.

Funding Highlights

Ramp raised $500 million to increase its AI-powered finance stack, whereas MapLight Therapeutics locked in $372.5 million to advance neurological drug therapies. Robotics upstart Apptronik landed a jaw-dropping $350 million Collection A to place humanoid robots into warehouses and factories. In the meantime, Observe, Anaconda, and Noma Safety every pulled in nine-figure rounds to gas software program observability, open-source AI tooling, and next-gen cybersecurity for enterprise AI programs.

Healthtech, semiconductors, and protection additionally made a robust exhibiting. Artbio secured $132 million for precision most cancers therapies, FuriosaAI raised $125 million to broaden its AI chip platform, and Delian Alliance emerged with $14 million to convey autonomous protection programs to the entrance strains of European safety.

Investor Exercise

The week noticed aggressive participation from heavyweights like Iconiq, Perception Companions, Goldman Sachs, Sanofi, DeepMind, Mubadala, Sutter Hill, and B Capital—signaling a transparent urge for food for disruptive innovation at scale. Whether or not backing software program, silicon, or artificial biology, enterprise buyers are inserting large bets throughout all sectors.

Under is the total breakdown of this week’s high startup and tech funding rounds—full with deep dives, investor rosters, and deal phrases.

Right here’s the total breakdown. Till subsequent week, have an important weekend.

Ramp Raises $500M Collection E-2 Funding to Broaden AI-Powered Finance Platform

Ramp, a New York-based expense administration fintech startup, raised a hefty $500 million in a Series E-2 round to speed up its AI-driven company finance instruments. The funding — which reportedly values Ramp at $22.5 billion — was led by Iconiq Capital with participation from present backers together with Founders Fund and D1 Capital. Coming simply weeks after a previous elevate, this new infusion will gas Ramp’s enlargement of its “finance co-pilot” AI brokers that automate expense reviews, invoice funds, and different back-office duties for the corporate’s 40,000 enterprise clients.

Based in 2019 by Eric Glyman, Gene Lee, and Karim Atiyeh, Ramp began as a company card platform to assist corporations lower your expenses. It has since grown right into a complete finance automation stack dealing with all the pieces from journey and bookkeeping to vendor administration. With this newest funding, Ramp plans to double down on product improvement and scaling, aiming to additional streamline how companies handle spend and money movement.

Funding Particulars:

• Startup: Ramp

• Buyers: Iconiq Capital (lead); Founders Fund, D1 Capital, amongst others

• Quantity Raised: $500 million

• Whole Raised: $1.9 billion

• Funding Stage: Collection E-2

• Funding Date: July 30, 2025

MapLight Therapeutics Secures $372.5M in Collection D Funding for Neuroscience Drug Pipeline

MapLight Therapeutics, a California-based biotech startup concentrating on mind and central nervous system problems, landed a colossal $372.5 million Series D round to advance its neuroscience drug pipeline. The financing was co-led by life sciences buyers Forbion and Goldman Sachs’ options unit, with vital participation from pharmaceutical big Sanofi and T. Rowe Worth, amongst different backers. This enormous elevate positions MapLight to push its lead therapeutic candidate (often known as ML-007C-MA, for schizophrenia and Alzheimer’s-related psychosis) by way of Part 2 scientific trials and scale up manufacturing.

With the contemporary capital, MapLight may also discover extra indications for its lead drug whereas accelerating different preclinical and scientific packages in its pipeline. The startup goals to problem entrenched neuropharmaceutical approaches by growing more practical therapies for psychiatric and neurological illnesses. The Collection D funding – one of many largest biotech rounds this 12 months – underscores sturdy investor conviction in MapLight’s science and its potential to deal with unmet wants in mind well being.

Funding Particulars:

• Startup: MapLight Therapeutics

• Buyers: Forbion and Goldman Sachs Alternate options (co-leads); participation from Sanofi, T. Rowe Worth, Avego Capital; present backers together with Novo Holdings, 5AM Ventures, Blue Owl, amongst others

• Quantity Raised: $372.5 million

• Whole Raised: Not disclosed

• Funding Stage: Collection D

• Funding Date: July 28, 2025

Apptronik Attracts $350M in Collection A Funding to Construct Humanoid Robots

Apptronik, an Austin-based robotics startup spun out of the College of Texas, secured $350 million in a massive Series A round to scale manufacturing of its Apollo humanoid robots for real-world work. The spherical — one of many largest Collection A financings ever for a robotics firm — was co-led by B Capital and Capital Manufacturing facility, with Google’s DeepMind collaborating as a strategic investor. Apptronik has been growing general-purpose humanoid robots in collaboration with NASA, and this funding will speed up manufacturing and deployment of its AI-powered robots, aiming to have them working in logistics and industrial environments by 2026.

By combining superior robotics engineering with cutting-edge AI, Apptronik’s Apollo robotic is designed to function safely alongside people and automate bodily demanding duties. The startup will use the brand new capital to broaden its engineering and manufacturing groups and to refine Apollo’s capabilities to be used instances like warehouse operations, manufacturing line work, and different labor-intensive jobs. Apptronik’s outstanding Collection A spherical displays rising confidence that humanoid robots might quickly turn into a sensible a part of the workforce.

Funding Particulars:

• Startup: Apptronik

• Buyers: B Capital and Capital Manufacturing facility (co-leads); participation from Google (DeepMind)

• Quantity Raised: $350 million

• Whole Raised: Roughly $378 million

• Funding Stage: Collection A

• Funding Date: July 31, 2025

Observe Raises $156M in Funding to Improve AI-Powered Software program Observability Platform

Observe, a San Mateo-based enterprise software program startup, raised $156 million in new funding to tackle monitoring giants like Datadog and Splunk with its AI-driven observability platform. The Collection C spherical was led by Sutter Hill Ventures and joined by Madrona Enterprise Group, Alumni Ventures, and the enterprise arms of Snowflake and Capital One. Observe’s cloud-based platform centralizes an organization’s logs, metrics, and hint knowledge on a Snowflake knowledge lake, utilizing automation and AI to assist engineers troubleshoot advanced programs sooner and extra simply.

With roughly 100 enterprise clients and fast income progress, Observe plans to make use of this massive infusion to additional improve its product — together with constructing out natural-language AI assistants for querying system knowledge — and to broaden its go-to-market presence throughout North America. Based in 2017, Observe got down to simplify the explosion of operational knowledge generated by trendy purposes. The newest funding will allow the corporate to scale its crew and proceed innovating within the high-demand area of software program observability as enterprises grapple with ever extra advanced IT stacks.

Funding Particulars:

• Startup: Observe

• Buyers: Sutter Hill Ventures (lead); Madrona Ventures, Alumni Ventures, Snowflake Ventures, Capital One Ventures

• Quantity Raised: $156 million

• Whole Raised: Over $270 million

• Funding Stage: Collection C

• Funding Date: July 30, 2025

Anaconda Snags $150M in Collection C Funding to Broaden Open-Supply AI Instruments

Anaconda, an Austin-based supplier of open-source software program for knowledge science and AI improvement, has raised $150 million in a Series C round led by Perception Companions. Abu Dhabi’s Mubadala Capital additionally joined the financing, which reportedly values the corporate at about $1.5 billion. Anaconda is well-known within the developer group for its common Python distribution and package deal administration platform, utilized by over 40 million knowledge scientists, researchers, and engineers worldwide. The contemporary funds will help Anaconda’s product improvement (together with new enterprise options and cloud choices), potential strategic acquisitions, and worldwide enlargement to satisfy surging international demand for AI developer instruments.

Based in 2012 by Peter Wang and Travis Oliphant, Anaconda helped make the Python programming language extra accessible for large knowledge analytics and machine studying work. As Python’s reputation exploded — turning into the world’s most-used programming language — Anaconda grew right into a central hub for AI and knowledge science software program. With greater than 300 staff and a broad suite of open-source and business choices, Anaconda’s new capital will allow it to speed up innovation and higher serve companies adopting AI at scale.

Funding Particulars:

• Startup: Anaconda

• Buyers: Perception Companions (lead); Mubadala Capital

• Quantity Raised: $150 million

• Whole Raised: Not disclosed

• Funding Stage: Collection C

• Funding Date: July 31, 2025

Artbio Raises $132M in Collection B Funding to Advance Most cancers Radiotherapies

Artbio, a U.S.-based radiopharmaceutical startup growing alpha-particle therapies for most cancers, secured $132 million in Series B funding to speed up its lead drug program. The spherical was co-led by Sofinnova Investments and B Capital, with participation from present buyers F-Prime Capital, Omega Funds, and Third Rock Ventures, plus new backers together with the Qatar Funding Authority (QIA) and Alexandria Enterprise Investments. Artbio’s platform focuses on alpha-emitting radiotherapy, which delivers potent, extremely focused radiation to tumor cells whereas minimizing harm to wholesome tissue. Its lead candidate is a remedy for metastatic prostate most cancers, now transferring into Part 2 trials.

With the brand new funding, Artbio will push its prostate most cancers remedy by way of the subsequent section of scientific testing and in addition broaden its radioisotope manufacturing community in anticipation of later-stage improvement and commercialization. The funding will moreover assist advance Artbio’s different pipeline packages addressing totally different cancers. By harnessing the precision of alpha-particle radiation, Artbio goals to create a brand new class of focused most cancers therapies — an method that has attracted each biotech-focused VCs and strategic healthcare buyers on this sizable spherical.

Funding Particulars:

• Startup: Artbio

• Buyers: Sofinnova Investments and B Capital (co-leads); present buyers F-Prime, Omega Funds, Third Rock Ventures; new buyers QIA (Qatar Funding Authority), Alexandria Enterprise Investments

• Quantity Raised: $132 million

• Whole Raised: Not disclosed

• Funding Stage: Collection B

• Funding Date: July 29, 2025

FuriosaAI Lands $125M to Scale Vitality-Environment friendly AI Chips

FuriosaAI, a Seoul-based semiconductor startup, has closed a $125 million Series C (bridge) funding round to ramp up manufacturing of its next-generation AI chips. The elevate was backed by a consortium of main Korean buyers, together with Korea Growth Financial institution, Industrial Financial institution of Korea, Keistone Companions, and Kakao Funding. Based in 2017, FuriosaAI designs high-performance AI inference accelerators that intention to ship larger effectivity for working giant AI fashions in knowledge facilities. Its “RNGD” chip structure is constructed to sort out the ability and price limitations of right this moment’s GPU-based infrastructure for synthetic intelligence workloads.

This new capital brings FuriosaAI’s whole funding to about $246 million and values the corporate at roughly $735 million. The startup plans to make use of the funds to scale up international manufacturing of its present chips and speed up improvement of its next-gen processors. As demand soars for extra environment friendly AI {hardware} – and nations like South Korea push to domesticate home chip champions – FuriosaAI is positioning itself as a key participant within the race to energy the AI growth with specialised silicon.

Funding Particulars:

• Startup: FuriosaAI

• Buyers: Korea Growth Financial institution, Industrial Financial institution of Korea, Keistone Companions, Kakao Funding (amongst others)

• Quantity Raised: $125 million

• Whole Raised: $246 million

• Funding Stage: Collection C (bridge spherical)

• Funding Date: July 30, 2025

Noma Safety Grabs $100M in Collection B Funding to Defend AI Techniques from Cyber Threats

Noma Security, an Israeli cybersecurity startup targeted on safeguarding AI fashions and enterprise knowledge from rising threats, has raised $100 million in a Series B round to broaden its platform. The funding was led by Evolution Fairness Companions (a U.S.-based VC agency), with continued participation from Ballistic Ventures and Israel’s Glilot Capital. This spherical brings Noma’s whole financing to $132 million to this point. The startup plans to make use of the capital to develop its R&D crew in Tel Aviv and scale its operations throughout North America, Europe, the Center East, and Africa, as extra organizations search options to safe their AI deployments.

Rising from stealth in late 2024, Noma rapidly gained traction with giant enterprises by addressing the “human and AI agent” safety hole. Its platform helps corporations detect and neutralize malicious AI actions and vulnerabilities in actual time. Over the previous 12 months, Noma reviews that it grew annual recurring income by over 1,300% and deployed its expertise at dozens of enterprises throughout finance, healthcare, retail, and tech. With AI programs turning into mission-critical (and more and more focused), Noma’s large Collection B spherical indicators sturdy investor confidence in its means to guard this subsequent wave of enterprise expertise.

Funding Particulars:

• Startup: Noma Safety

• Buyers: Evolution Fairness Companions (lead); Ballistic Ventures, Glilot Capital

• Quantity Raised: $100 million

• Whole Raised: $132 million

• Funding Stage: Collection B

• Funding Date: July 31, 2025

Ultromics Diagnoses $55M in Collection C Funding for AI-Powered Coronary heart Scans

Ultromics, an Oxford, UK-based healthtech firm utilizing AI to detect coronary heart illness from ultrasound pictures, raised $55 million in Collection C funding to broaden its platform within the U.S. healthcare market. The spherical was co-led by Authorized & Basic and Allegis Capital, alongside progress investor Lightrock, with extra help from present backers together with Oxford Science Enterprises, GV (Google Ventures), UCM Ventures, UPMC Enterprises, and the Blue Enterprise Fund. Ultromics’ flagship product, EchoGo, is FDA-cleared software program that applies synthetic intelligence to echocardiograms to identify early indicators of coronary heart failure and different cardiac situations extra precisely and effectively than conventional strategies.

The brand new funding will assist Ultromics deploy EchoGo at scale throughout hospitals and clinics, develop its product pipeline (doubtlessly extending into different cardiovascular diagnostics), and forge additional partnerships with healthcare suppliers and insurers. By bettering the pace and accuracy of ultrasound-based prognosis, Ultromics goals to allow earlier intervention for coronary heart illness and higher outcomes for sufferers. The corporate’s newest spherical will speed up its U.S. enlargement and continued innovation on the intersection of AI and cardiology.

Funding Particulars:

• Startup: Ultromics

• Buyers: Authorized & Basic, Allegis Capital, Lightrock (co-leads); participation from Oxford Science Enterprises, GV (Google Ventures), Blue Enterprise Fund, UCM Ventures, UPMC Enterprises

• Quantity Raised: $55 million

• Whole Raised: Not disclosed

• Funding Stage: Collection C

• Funding Date: July 31, 2025

Delian Alliance Industries Raises $14M to Scale Autonomous Protection Techniques

Delian Alliance Industries, an Athens-based protection tech startup based by former Apple engineer Dimitrios Kottas, has raised $14 million in Collection A funding to develop autonomous military-grade programs. The spherical was co-led by Air Avenue Capital and Marathon Enterprise Capital, with participation from 201 Ventures, HCVC, Entropy Industrial Capital, and Nebular. Delian Alliance is constructing AI-powered protection platforms — comparable to unmanned aerial drones and automatic surveillance towers — to satisfy the rising demand for cutting-edge safety and protection expertise in Europe.

The corporate plans to make use of the funds to broaden its engineering crew and speed up the manufacturing and area deployment of its programs. Curiosity in Delian’s expertise is already rising from NATO companions and different allied protection organizations seeking to bolster their capabilities with superior autonomy. By combining sturdy {hardware} with clever software program, Delian Alliance goals to supply militaries and protection contractors with next-generation instruments for surveillance, reconnaissance, and drive safety. This early-stage funding will assist the startup scale up manufacturing and navigate the rigorous testing and procurement processes within the protection sector.

Funding Particulars:

• Startup: Delian Alliance Industries

• Buyers: Air Avenue Capital and Marathon VC (co-leads); 201 Ventures, HCVC, Entropy Industrial Capital, Nebular

• Quantity Raised: $14 million

• Whole Raised: Roughly $20 million

• Funding Stage: Collection A

• Funding Date: July 29, 2025

Tech Funding Abstract Desk